Roy Bicknell

Publications

  1. 2020
  2. Published
  3. Published

    CAR T-cells targeting tumor endothelial marker CLEC14A inhibit tumor growth

    Joseph Robinson, Neeraj Jumbu, Jonas Bystrom, Zsuzsanna Nagy, Roy Bicknell & Steve Lee, 2 Oct 2020, In : JCI Insight. 5, 19, 19 p., e138808.

    Research output: Contribution to journalArticlepeer-review

  4. 2019
  5. Published
  6. Published

    C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation

    Fiyaz Mohammed & Roy Bicknell, 2 Sep 2019, In : The FEBS journal. 286, 17, p. 3299-3332 34 p.

    Research output: Contribution to journalReview articlepeer-review

  7. 2017
  8. Published

    Antibodies and related molecules and uses thereof

    Steve Lee & Roy Bicknell, 21 Sep 2017, Patent No. WO/2017/158339

    Research output: Patent

  9. Published

    Chimeric antigen receptor

    Steve Lee, Roy Bicknell, 21 Sep 2017, Patent No. WO2017158337

    Research output: Patent

  10. E-pub ahead of print
  11. Published
  12. Published

    Sunitinib treatment enhances metastasis of innately drug resistant breast tumors

    Joseph Wragg, Victoria Heath & Roy Bicknell, 1 Feb 2017, In : Cancer Research. 77, 4, p. 1008-1020 12 p.

    Research output: Contribution to journalArticlepeer-review

  13. 2016
  14. Published

    Glutamate Receptor 2D is a novel angiogenic tumour endothelial marker in colorectal cancer

    Joseph Wragg, Stephen Ward, Victoria Heath & Roy Bicknell, 12 May 2016, In : OncoTarget. 7, 15, p. 20440-20454

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 5 6 7 8 Next